HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of postmortem changes on immunohistochemical reactions in skin.

Abstract
The influence of postmortem damage of tissues on the immunohistochemical diagnosis of wound age has not as yet been clarified. We utilized antibodies against the proteinase inhibitors alpha-1-antichymotrypsin and alpha-2-macroglobulin, fibronectin and lysozyme to study samples of skin which had been intact intravitally, but were damaged postmortem either by autolysis or compression with a surgical clamp at the time of dissection. Even in the absence of autolysis, antibodies against the proteinase inhibitors and fibronectin exhibited staining of tissue margins. Autolysis caused an increase in false positive results. In contrast, antibodies against lysozyme did not give false positive staining. There were no antigens sensitive to postmortem clamping and false positive results were not observed. Antibodies against proteinase inhibitors are not useful for the diagnosis of wound age because of a high number of false positive reactions in marginal areas. Fibronectin also showed false positive band-shaped staining patterns at the tissue margin. In addition, autolytic processes increase the number of false positives. The antibody against lysozyme is much less sensitive to autolysis and no false positive reactions were observed in our series of tests.
AuthorsA Fieguth, W J Kleemann, R von Wasielewski, M Werner, H D Tröger
JournalInternational journal of legal medicine (Int J Legal Med) Vol. 110 Issue 1 Pg. 18-21 ( 1997) ISSN: 0937-9827 [Print] Germany
PMID9081235 (Publication Type: Journal Article)
Chemical References
  • Fibronectins
  • alpha 1-Antichymotrypsin
  • alpha-Macroglobulins
  • Muramidase
Topics
  • Fibronectins (analysis)
  • Humans
  • Immunoenzyme Techniques
  • Muramidase (analysis)
  • Postmortem Changes
  • Reference Values
  • Sensitivity and Specificity
  • Skin (pathology)
  • alpha 1-Antichymotrypsin (analysis)
  • alpha-Macroglobulins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: